Dec. 20, 2019 Price forecast | 2 weeks: -3.10% | 1 month: -7.56% | 3 months: -7.94%


MEDP stock forecast

Our latest prediction for Medpace Holdings, Inc.'s stock price was made on the Dec. 20, 2019 when the stock price was at 84.42$.

In the short term (2weeks), MEDP's stock price should underperform the market by -3.10%. During that period the price should oscillate between -5.94% and +4.09%.

In the medium term (3months), MEDP's stock price should underperform the market by -7.94%. During that period the price should oscillate between -18.56% and +11.82%.


About Medpace Holdings, Inc.

Medpace Holdings, Inc. is a contract research organization, which engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

At the moment the company generates 823M USD in revenues.

On its last earning announcement, the company reported a profit of 2.49$ per share.

The book value per share is 15.18$

Medpace Holdings, Inc. website


Three months stock forecastDec. 20, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
823M 29.60% 122M 14.80% 93M 2.49 - - 37M 15.18 184M -16M 169M